Clinical Trial Update: Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 trial update examining extended-release torsemide in patients with congestive heart failure and overactive bladder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Torsemide (extended-release) (torsemide)

Snippet

Sponsor: Sarfez Pharmaceuticals, Inc. | Conditions: Heart Failure, Overactive Bladder | Phase 2 | Status: COMPLETED